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ABSTRACT 22 
The microalgae are an important source of bioactive molecules including b-glucans that can be 23 
used as immunostimulants in aquaculture. In the present study, the antioxidant capacity, 24 
cytotoxicity and immunomodulatory activity of a chrysolaminarin-enriched extract obtained from 25 
the diatom Phaeodactylum tricornutum was evaluated. The extract showed a higher total 26 
antioxidant activity as determined by ORAC and FRAP assays and a lower DPPH scavenging 27 
activity than particulate yeast-b-glucan. The cytotoxicity test indicated that extract concentrations 28 
higher than 0.01% w/v could impair cell viability of human dermal fibroblasts. To evaluate the 29 
immunomodulatory activity, juvenile soles were intraperitoneally injected with the 30 
chrysolaminarin-enriched extract suspended in coconut oil (1 mg/fish) followed by a reinjection 31 
at 7 days. A sham group injected with the carrier solution was maintained as a negative control. 32 
Cumulated mortality of fish injected with the chrysolaminarin-enriched extract was 29.4% after 33 
six days and no mortality was recorded after extract reinjection. Expression analyses of fifteen 34 
genes related to the innate immune system in kidney, spleen and intestine showed temporal and 35 
organ-specific responses. A rapid (2 days post-injection; dpi) and strong induction of the pro-36 
inflammatory il1b and the antimicrobial peptide hamp1 in the three immunological organs, the 37 
hsp90aa in kidney and spleen, irf3 in intestine and c3 in spleen was observed indicating a potent 38 
inflammatory response. The recovery of steady-state levels for all activated genes at 5 dpi, and 39 
the down-regulation of c-lectin receptor as well as some interferon-related genes (ifn1, irf1, irf3, 40 
irf8, irf9 and mx) in kidney and cxc10 in spleen indicated that the soles were able to activate a 41 
homeostatic response against the β-glucan insult. The reinjection of the chrysolaminarin-enriched 42 
extract did not activate a new inflammatory response but reduced the mRNA levels of hsp90aa 43 
and irf3 indicating that soles developed some resistance to β-glucans. Overall, these results reveal 44 
this enriched extract as a novel and potent source of β-glucans with antioxidant and 45 
immunomodulatory capacity suitable for immunostimulation in aquaculture.  46 
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1. Introduction 49 
The b-glucans are considered as potent immunosaccharides able to enhance the immune 50 
response and prevent disease outbreaks [1, 2]. These bioactive molecules activate the 51 
production of pro- and anti-inflammatory cytokines, which in turn modulate humoral and 52 
cellular immunity through different pathways conferring antimicrobial, antitumor and 53 
anti-proliferative properties [3-5]. Moreover, b-glucans exhibit antioxidant, anti-diabetic, 54 
and anti-obesity effects [3, 6] and the broad spectrum of applications in biotechnology 55 
and biomedicine fields makes them of high biotechnological and biomedical interest. In 56 
aquaculture, b-glucans are mainly used as immunostimulants and prebiotics and are 57 
administered by injection or as a dietary supplement able to enhance fish growth, survival 58 
and the immune response and also improve resistance to several different pathogens [2, 59 
7]. Moreover, recent findings that reported a role of β-glucans on trained immunity by 60 
epigenetic reprogramming of monocyte-to-macrophage differentiation [8-10] have even 61 
increased the interest on these polysaccharides. 62 
The b-glucans are widely distributed in the nature and can be obtained from different 63 
sources such as bacteria, algae, fungi and plants. They share a common basic structure 64 
and are composed of glucose homopolymers bound together by glycoside bonds. The 65 
position and distribution of the glycoside bonds, molecular size and type, solubility and 66 
degree of branching, gives each b-glucan a unique structure and specific bioactive 67 
properties [2, 11-13]. The antioxidant and anti-proliferative properties of b-glucans from 68 
fungi and plants have been extensively studied for food and clinical uses [6, 14-16]. In a 69 
similar way, b-(1,3;1,6)-glucans from yeast are the most used in aquaculture as 70 
immunostimulants and to a lesser extent b-(1,3;1,6) from seaweeds (laminarin) or b-71 
(1,3;1,4) from cereal grains [2, 7]. However, little information is available about the 72 
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antioxidative properties and immunomodulatory actions of b-glucans from microalgae, 73 
the chrysolaminarin (also known as leucosin). 74 
Chrysolaminarin is a soluble b-glucan synthetized for energy storage by several marine 75 
microalgae including haptophyte and stramenopiles (such as diatoms and 76 
Nannochloropsis) [15, 17, 18]. The biosynthesis of this polysaccharide is highly dynamic 77 
relying on light and nutrient levels and also shows growth-phase dependency [19-22]. 78 
Unlike glucans from fungi and plants, chrysolaminarin is low molecular weight (1-40 79 
kDa) and contains only 20-30 linear residues with a low degree of branching [15, 18]. 80 
The interest in recent years in the production of biomass from the diatom Phaeodactylum 81 
tricornutum has rapidly grown due to its biosynthetic capacity and high growth rates and 82 
it is regarded as a valuable resource for novel food supplements, cosmeceuticals and 83 
several other industrial applications [23, 24]. The chrysolaminarin cell content in this 84 
diatom ranges between 4.9-17.1% of the dry mass and its isolation can be combined with 85 
the purification of other bioproducts such as pigments and lipids [15, 21, 22, 25]. 86 
Although several species of microalgae are used as a feed source in fish hatcheries [26], 87 
no information about the bioactivity of chrysolaminarin exists in fish. 88 
The aquaculture production of the flatfish Senegalese sole is rapidly growing in Europe 89 
with large investments in advanced recirculation facilities to transform production into a 90 
highly intensive model [27]. However, this development needs to be accompanied by 91 
disease control and prevention measures so as to reduce the risks of disease outbreaks and 92 
minimize the use of chemicals. Currently the aquaculture of this species is mainly threated 93 
by bacterial diseases such as Vibriosis, Photobacterium damselae piscicida and 94 
Tenacibaculum spp. [28] and several prevention strategies such as inactivated vaccines 95 
[29] or phage therapy [30] are under investigation. The use of immunostimulants such as 96 
 –5– 
b-glucans suitable to be incorporated as vaccine adjuvants or feed supplements is another 97 
strategy successfully used for several other species [1, 2, 7, 31]. The aims of the present 98 
study were: i) characterize the antioxidant properties of a chrysolaminarin-enriched 99 
extract from P. tricornutum; ii) study its in vivo and in vitro toxicity; iii) evaluate the 100 
transcriptional response after intraperitoneal injection in juveniles. The results obtained 101 
demonstrate the antioxidant and immunomodulatory actions of this microalgal extract 102 
enriched in this unexplored b-glucan, still relatively little exploited by the aquaculture 103 
industry. 104 
2. Materials and methods 105 
2.1 Microalgae cell culture and b-glucan sources 106 
The P. tricornutum strain used in this study was obtained from the Microalgae Culture 107 
Collection of Fitoplancton Marino, S.L. (CCFM). Microalgae were initially grown 108 
indoors using autoclaved seawater (salinity 33 psu) enriched with filter-sterilized f/2 109 
nutrients in 50 mL flasks bubbled filter-sterilized CO2-enriched air (2%). Microalga 110 
cultures were carried out in a temperature-controlled room (22ºC) under continuous 111 
illuminating conditions using artificial daylight fluorescent light (150 μmol μEm−2s−1). 112 
Once the cultures reached the early stationary phase they were used to inoculate in 1 L 113 
culture flasks. This process of scaling up in volume was repeated until reach 50 L cultures, 114 
which were then used to inoculate in the outdoor photobioreactors (PBRs). Light-dark 115 
cycles and ambient temperature were influenced by seasonal environmental conditions 116 
(10-11 h of light, temperatures ranging from 10-22 ºC) and pH was controlled by CO2 117 
injection when necessary. Cells were harvested by continuous-flow centrifugation 4 h 118 
after sunrise, frozen at -20 ºC and freeze-dried for further use.  119 
The chrysolaminarin-enriched crude extract was prepared at Fitoplancton Marino using 120 
the warm-water extraction method [32] with slight modifications. Freeze-dried 121 
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microalgae were heated under alkaline pH conditions and the proteins were later 122 
precipitated by a pH-shift approach after removing cell debris. The supernatant containing 123 
the polysaccharides was precipitated by adding absolute ethanol (1 v:v) for 24h at 4ºC. 124 
After collecting the precipitates by centrifugation, they were frozen at -80ºC and 125 
preserved by freeze-drying. This chrysolaminarin-enriched crude extract was 126 
characterized by the phenol-sulfuric acid method [33] indicating a 47.3% reducing sugar 127 
with ~5% of total protein as determined by the Bradford assay. The particulate (1,3)-128 
(1,6)-b-glucan (Yestimun®) from brewers' yeast was purchased from Quimivita 129 
(Barcelona, Spain; 42200P-030). 130 
2.2 Total antioxidant capacity assays 131 
The total antioxidant capacity (TAC) of the yeast b-glucan and the chrysolaminarin-132 
enriched extract (1% w/v) were measured using three methods: oxygen radical 133 
absorbance capacity (ORAC) assay, ferric reducing antioxidant power (FRAP) and the 134 
2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging assay. The ORAC assay 135 
was carried out using fluorescein as the probe as described by Gillespie et al. [34]. ORAC 136 
values were calculated by subtracting the area under the blank curve from the area under 137 
the sample curve (Net AUC) and expressed as Trolox equivalents (μmol Trolox/g). FRAP 138 
assays were carried out according to Benzie and Strain [35] and the results were expressed 139 
as μg ascorbic acid/mg of b-glucan dry mass. DPPH assays were performed according to 140 
Molyneux [36]. DPPH activities were expressed as % free radical scavenging and the IC50 141 
values (the amounts of b-glucan (mg) required to scavenge 50% DPPH radicals) were 142 
also estimated. 143 
2.3 Human skin cell culture and cytoxicity tests 144 
Primary Normal Human Dermal Fibroblasts (NHDF) isolated from normal human adult 145 
skin were purchased from Lonza CloneticsTM (Lonza Walkersville, USA) and cultured as 146 
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previously described [37]. The cell proliferation test was assessed by using an MTT kit 147 
(Vybrant MTT cell proliferation assay kit, Thermo Fisher Scientific) according to the 148 
manufacture's protocol. The MTT assay is based on the reduction of the tetrazolium salt, 149 
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) by actively 150 
growing cells to produce blue formazan product. NHDF were incubated with different b-151 
glucan concentrations (ranging 0.001-1% w/v in a final volume of 100 µL) for 24h and 152 
optical density measured at 570 nm. 153 
2.4 Fish trials 154 
All procedures were authorized by the Bioethics and Animal Welfare Committee of 155 
IFAPA and given the registration number 26–11–15-374 by the National authorities for 156 
regulation of animal care and experimentation.  157 
The chrysolaminarin-enriched extract was intraperitoneally (i.p.) injected using coconut 158 
oil (Renuka Agri Organics LTD) as a vehicle for a slow and prolonged release of the 159 
polysaccharide. The freeze-dried extract was firstly suspended in PBS, then added the 160 
same volume (1:1) of coconut oil and vortexed to generate an emulsion. A control solution 161 
mix using the same 1:1 PBS: coconut oil proportion but without extract was also prepared 162 
and used for injection to the sham control. The experimental design is depicted in Figure 163 
1. A total of 70 specimens of sole (average weight 19.3±3.3g) were supplied by Cupimar 164 
S.A. (San Fernando, Cádiz, Spain). The animals were distributed into eight cylindrical 165 
tanks (1 m2 surface) in an open flow-through circuit. The animals were kept for one week 166 
before starting the experiment and fed with commercial diets (Skretting; 1% biomass). 167 
Before manipulating the animals, they were sedated with phenoxyethanol (100 ppm final 168 
concentration). Four tanks (10 specimens each) were given intraperitoneal (i.p)  injections 169 
of 100 µL of the chrysolaminarin-containing solution (1 mg/fish). This dose of 170 
chrysolaminarin by i.p. injection was selected based on a previous study [38]. Moreover, 171 
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three tanks (10 specimens each) were injected with the control solution (sham control 172 
group). Mortality was monitored daily and six animals per treatment (two specimens from 173 
each tank remaining the fourth tank in chrysolaminarin-injected fish untouched) were 174 
sampled at 2 and 5 days post injection (dpi) and organs collected. Animals were 175 
euthanized using an overdose of phenoxyethanol (250 ppm final concentration) and the 176 
kidney, spleen and intestine dissected out. Samples for gene expression analysis were 177 
fixed in RNA-later (Invitrogen) and stored at -80°C until use. In the trial, a temperature 178 
of 22.3ºC±0.6, dissolved oxygen of 6.5±0.5 ppm, and salinity of 40.2±1 psu were 179 
recorded. At 7 dpi, 27 surviving specimens were given a second i.p. injection of 180 
chrysolaminarin-enriched extract (1 mg/fish, 14 specimens; group Chr_Chr) or the 181 
control solution (13 specimens; group Chr_C) and distributed into four tanks. All fish 182 
from sham control group were again injected only with the control solution (30 183 
specimens; group C_C) and distributed into three tanks. In the trial, a temperature of 184 
20.8ºC±0.7, dissolved oxygen of 6.0±0.7 ppm, and salinity of 38.5±0.6 ppt were recorded. 185 
Mortality was monitored daily and two animals per tank were sampled at 2 dpi. Fish were 186 
euthanized and samples collected as indicated above. 187 
 188 
2.5 RNA isolation and RT-qPCR analysis 189 
Total RNAs from the intestine (~40-50 mg) and spleen (~15 mg) was isolated using the 190 
NucleoSpin RNA isolation Kit (Macherey-Nagel) following the manufacturer's protocol. 191 
Samples were homogenized in the Fast-prep FG120 instrument (Bio101) using Lysing 192 
Matrix D (Q-Bio-Gene) for 60 s at speed setting 6. In the case of kidney (~10-15 mg), 193 
tissue homogenization was carried out as indicated above using 1 ml of TRI-Reagent 194 
(Sigma-Aldrich). After adding chloroform (0.2 mL) and centrifugation, the aqueous 195 
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phase was transferred to columns of the NucleoSpin RNA isolation Kit (Macherey-Nagel) 196 
to complete the RNA purification in a similar way to intestine and spleen. Isolated RNA 197 
samples were treated twice on-column with DNase with DNase I using a NucleoSpin 198 
RNA isolation Kit (Macherey-Nagel) for 30 min. RNA sample quality was checked by 199 
agarose gel electrophoresis and quantification was determined spectrophotometrically 200 
using the Nanodrop ND-8000 (Thermo Scientific). 1 µg of total RNA was reverse-201 
transcribed using the iScriptTM cDNA Synthesis kit (Bio-Rad) according to the 202 
manufacturer’s protocol.  203 
To evaluate the immunomodulatory effects of chrysolaminarin the following gene panel 204 
was selected: pro-inflammatory cytokines: interleukin 1b (il1b) and tumor necrosis factor 205 
alpha (tnfa); cellular stress: heat shock protein 90 alpha (hsp90aa); antimicrobial peptide: 206 
hepcidin (hamp1); bacterial defence: g-type lyzozyme (g-lys); chemokine: cxc10; 207 
complement factor (c3); antiviral defence: interferon 1 (ifn1), interferon-induced Mx 208 
protein (mx), interferon-related factors (irf1, irf3, irf7, irf8 and irf9); glucan receptor c-209 
type lectin (clec). Primers for amplification of hsp90aa, hamp1, mx, irf1 and irf3 and the 210 
reference genes ubi and actb1 were previously published [39-43]. Primers used for 211 
amplification of il1b, tnfa, c3, clec, cxc10, ifn1, irf7, irf8 and irf9 (Table 1) were designed 212 
using the Oligo v7 software using specific sequences from SoleaDB [44]. The c-lectin 213 
receptor was identified by blasting the salmon glucan receptor sequences for sclrc genes 214 
[45]. 215 
Real-time analysis was carried out on a CFX96TM Real-Time System (Bio-Rad). Real-216 
time reactions were performed in a 10 µL volume containing cDNA generated from 10 217 
ng of original RNA template, 300 nM each of specific forward and reverse primers, and 218 
5 µL of SYBR Premix Ex Taq (Takara, Clontech). The amplification protocol used was 219 
as follows: initial 7 min denaturation and enzyme activation at 95ºC, 40 cycles of 30 s at 220 
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95ºC, 15 s at 68°C and 30 s at 72°C. Each PCR assay was performed in duplicate. The 221 
PCR protocol to amplify the mx gene was described in Fernandez-Trujillo et al. [43]. 222 
Data were normalized using the geometric mean of ubiquitin (ubi) and β-actin (actb1) 223 
[40] and relative mRNA expression calculated using the comparative Ct method [46]. 224 
PermutMatrix [47] was used to conduct a cluster analysis with the different experimental 225 
conditions analysed using log 10 of fold change with parameters set as following: 226 
Dissimilarity: Euclidean distance, Hierarchical: Complete Linkage Method, Seriation: 227 
Multiple-fragment heuristic (MF). 228 
2.6 Statistical analysis 229 
All data were checked for normal distribution with the Kolmogorov–Smirnov test as well 230 
as for homogeneity of variance with the Levene′s test and when necessary a log 231 
transformation was applied. Survival rates were assessed by using one-way ANOVA test. 232 
To test the existence of significant differences in gene expression in the injection trial, a 233 
two-way ANOVA was performed using treatment and time as fixed factors and in case 234 
of significance a Student's t-test was performed. For reinjection trial, a one-way ANOVA 235 
followed by an LSD post hoc test was carried out. Differences with p < 0.05 were 236 
considered to be statistically significant. Analyses were performed using SPSS v21 237 
software (IBM Corp., Armonk, NY, USA) and Statistix 9 (Analytical Software, 238 
Tallahassee, FL, USA).  239 
 240 
3. Results  241 
3.1 Antioxidant activities  242 
The total antioxidant capacity (TAC) as determined by ORAC, FRAP and DPPH is 243 
depicted in Figure 2. The chrysolaminarin-enriched extract had 14.2-folds higher TAC as 244 
determined by ORAC than particulate yeast β-glucan (29.8 ± 7.3 vs 2.1 ± 0.7 µmol Trolox 245 
 –11– 
g-1). In a similar way, chrysolaminarin-enriched extract also showed higher reducing 246 
antioxidant power than yeast β-glucan (1.0 ± 0.01 vs 0.2. ± 0.03 μg ascorbic acid/mg at 247 
concentration10 mg/ml). In contrast, DPPH radical scavenging activity was higher in the 248 
yeast β-glucan (estimated IC50 values were 1,896 ± 144 and 353 ± 28 μg/mL for the 249 
chrysolaminarin-enriched extract and yeast β-glucan, respectively).  250 
3.2 Cell toxicity and fish survival 251 
The cytotoxic activity of the chrysolaminarin-enriched extract and yeast β-glucan 252 
(ranging from 0.001 to 1% w/v final concentration) was assayed in the primary dermal 253 
cell cultures NHDF using the MTT assay (Fig. 3A). Cell survival with the microalgal 254 
crude extract was slightly higher (100%) than with yeast β-glucan (89.6%) at the lowest 255 
concentration (0.001%) and impaired cell viability was observed at 0.01%. Mortality was 256 
concentration-dependent in both β-glucans (only 39% survival at the highest 257 
concentration 1%).  258 
In vivo experiments using 0.005% w/w of chrysolaminarin-enriched extract resulted in 259 
29.4% cumulated mortality at 6 dpi (Fig. 3B). No mortality was detected in the sham 260 
control group (C_C). Moreover, reinjection of the chrysolaminarin-enriched extract or 261 
control solution at 7 dpi to the fish previously injected with the extract (Chr_Chr or Chr_C 262 
groups) did not provoke any additional mortality (Fig. 3B). 263 
3.3 Expression profiles in immunological organs 264 
To evaluate the immunomodulatory activity of the chrysolaminarin-enriched extract, 265 
transcript abundance of genes related to the inflammatory response, cellular stress, 266 
carbohydrate binding receptors and defence against bacteria and viruses was quantified 267 
in three immunological organs: kidney, spleen and intestine. A cluster analysis clearly 268 
separated the expression response observed in chrysolaminarin-injected soles from the 269 
sham control at 2 dpi in the tree organs studied (Fig. 4) while it was hardly observable at 270 
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5 dpi (only in kidney appeared separated both experimental groups). The injection of the 271 
microalgal extract rapidly (2 dpi) up-regulated the expression of il1b, hsp90aa and hamp1 272 
(5.6-, 12.5- and 4.9-folds, respectively) and down-regulated that of clec and ifn1 in the 273 
kidney with respect to the sham control. Later at 5 dpi, the antiviral defence genes irf1, 274 
irf3, irf8, irf9 and mx significantly decreased their expression levels (p < 0.05) (Fig. 5). 275 
The reinjection of the chrysolaminarin-enriched extract at 7 days (Chr_Chr group) only 276 
reduced significantly the expression of hsp90aa and irf3 with respect to both groups 277 
reinjected with the control solution (C_C and Chr_C groups). No change in gene 278 
expression was detected for il1b, tnfa, c3, hamp1, clec, ifnc, irf7 or mx (data not shown). 279 
In intestine and spleen a subset of ten genes was selected to evaluate the immune response 280 
(indicated in Fig. 4). In intestine, the mRNA levels of il1b, hamp1 and irf3 were up-281 
regulated 16.6-, 43.7- and 10.5-folds, respectively at 2 dpi and the c3 mRNA abundance 282 
significantly increased 4.4-fold at 5 dpi (Fig. 6). In the spleen, expression of il1b, 283 
hsp90aa, c3 and hamp1 increased 12.6-, 5.8, 5.4- and 10.0-folds, respectively at 2 dpi 284 
while cxc10 and irf3 mRNA levels significantly decreased (3.9- and 3.2-folds, 285 
respectively) at 5 dpi (Fig. 6). No change in gene expression was detected for tnfa, clec, 286 
irf7 and g-lys in intestine and spleen and for hsp90aa and cxc10 in intestine (data not 287 
shown). 288 
 289 
4. Discussion 290 
The advances in microalgae biomass production at an industrial scale have brought to the 291 
market novel bioproducts that can be feasible exploited as it is the case of 292 
chrysolaminarin. The antioxidant, prebiotic and immunostimulant activity of b-(1,3;1,6)-293 
glucans from different sources is well-recognized and hence, these polysaccharides have 294 
been proposed as potential functional dietary supplements or as vaccine adjuvants to 295 
enhance immune response in aquaculture [2, 9]. However, the antioxidant capacity and 296 
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immunomodulatory effects of these b-glucans in fish are still unexplored. In the present 297 
study the antioxidant capacity, citotoxicity and immune response of a chrysolaminarin-298 
enriched extract from the diatom P. tricornutum have been determined using the flatfish 299 
Senegalese sole as a model. These new data represent an initial study to develop new 300 
applications to functional extracts from microalgal biomass. 301 
Previous studies on b-glucans have demonstrated their antioxidant and reactive oxygen 302 
species scavenger activity [20, 48-50]. In this study, our chrysolaminarin-enriched extract 303 
from P. tricornutum also showed antioxidant activity with higher TAC than particulate 304 
yeast b-glucan in the ORAC (~14-folds) and FRAP (~4-folds) assays but lower in the 305 
DPPH scavenging method. We should note that although chrysolaminarin was a major 306 
component in our crude extract, we cannot fully discard a contribution to TAC of other 307 
minor cellular components. In fact, Kanmani et al. [51] reported that crude 308 
exopolysaccharide extracts had higher reducing power and hydroxyl radical scavenging 309 
activity than purified exopolysaccharide as consequence of secondary metabolites in the 310 
extract. Anyway, the contrasting results in the three TAC assays between the microalgal 311 
extract and yeast b-glucan could be explained by two main factors: a) the distinct 312 
structure, composition and solubility of b-glucans [52] and b) the specific 313 
thermodynamic, kinetic and chemical characteristics of each TAC assay and the oxidizing 314 
power of each TAC reagent against a given antioxidant [53]. The chrysolaminarin has a 315 
lower molecular weight (MW; ~10 kDa) and lower degree of polymerization (DP; 28-33) 316 
than yeast b-glucan (branch-on-branch, high MW (>200 kDa) and high DP (>100) [11, 317 
21, 54]. Such differences in size, branching and conformation play a key role in water-318 
solubility, a limiting factor in the FRAP assay [55] and hydroxyl radical scavenging 319 
activity [14]. A previous study in the microalga Odontella aurita demonstrated that 320 
chrysolaminarin had a stronger antioxidant activity for hydroxyl radical scavenging than 321 
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for DPPH radicals [20] indicating that structural differences are important for a better 322 
neutralization the peroxyl radicals in ORAC and total reducing power in FRAP. 323 
Moreover, those molecules with lower antioxidant values in the ORAC relative to the 324 
DPPH assay as observed in yeast b-glucan have been proposed to act both as antioxidants 325 
and powerful pro-oxidants and this makes chrysolaminarin b-glucan even more 326 
interesting for the food and cosmetic industry [56].  327 
Some β-glucans have been reported to exhibit anti-proliferative and antitumor activities. 328 
For example, laminarin impairs the viability of human lung fibroblasts at concentrations 329 
higher than 0.004% with high inhibition achieved at concentrations higher than 0.02% 330 
w/v [48]. However, when used at an appropriate dose in in vitro cell assays, laminarin 331 
has an antioxidant action that protects against reactive oxygen species [48]. Similarly, β-332 
glucans from cereals exert cytotoxic actions against cancerous cells at concentrations 333 
lower than 0.02% w/v [57]. The data from the present study indicate that chrysolaminarin-334 
enriched extract at concentrations higher than 0.01% w/v affected cell viability of human 335 
dermal fibroblasts as has previously been shown for other b-glucans. More research will 336 
be necessary to investigate the specific cancer-protective actions of this microalgal 337 
extract. Intriguingly, i.p. injection of this extract to soles induced a 29.4% mortality. This 338 
was unexpected since the dose used (1 mg/fish; 0.052mg/g) was close to the range 339 
previously used in other fish species (0.1-1mg/fish; 0.01-0.033 mg/g fish) [38, 58-60]. 340 
The absence of mortality after the second exposure to chrysolaminarin tends to preclude 341 
the presence of adulterating toxic substances such as endotoxins. As the main differences 342 
between the present and previous studies was the vehicle used for injection (coconut oil 343 
instead of phosphate-buffered saline for a slow delivery), we hypothesize that the 344 
prolonged release of chrysolaminarin triggered a sustained and potent inflammatory 345 
response (see below), that in turn resulted in a non-adaptive stress response, a failure in 346 
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homeostatic response and mortality. The exact mechanisms by which in vivo 347 
chrysolaminarin caused mortality will require further studies. 348 
The β-glucans from different sources are well-known as enhancers of non-specific 349 
immunity in fish through the activation of macrophages and the production of pro-350 
inflammatory cytokines. The i.p. injection of yeast β-glucan triggered the expression of 351 
il1b in carp head kidney macrophages after 24 and 48 h [38]. Moreover, laminarin i.p. 352 
injection activated the expression of il1b in salmonids using both in vitro (head kidney 353 
macrophages) and in vivo (in kidney and spleen after 48 h) approaches [60, 61]. The 354 
β(1,3) scleroglucan activated expression of il1b peritoneal cells of carp at 2 dpi due to 355 
inflammatory leucocyte migration [58]. The polysaccharides from the herb Astragalus 356 
containing β-glucans also increased il1b mRNA abundance in the head kidney of common 357 
carp (Cyprinus carpio). [62]. Our study demonstrates that i.p. injection of the 358 
chrysolaminarin-enriched extract in sole elicited a similar response to laminarin in other 359 
fish and rapidly activated the expression of the pro-inflammatory cytokine il1b (at 2 dpi) 360 
in the three organs analysed. This cytokine acts as a mediator of β-glucan actions and 361 
triggers a generalized downstream response through the NF-κB and MAPK signalling 362 
pathways to produce cytokines and activate the migration and phagocytic activities of 363 
macrophages [63]. It should be noted that magnitude of the il1b activation was higher in 364 
spleen and intestine than in kidney that also supports previous observations that reported 365 
the spleen as a major target for β-glucan actions with larger and more intense responses 366 
[60, 61, 64]. The lack of response of the pro-inflammatory cytokine tnfa could be due to 367 
a dose or time-point effect. A previous study indicated that the activation of tnfa was 368 
delayed with respect to il1b after β-glucan treatments in trout head kidney leukocytes [65] 369 
and also showed dose-dependent effects as demonstrated by in vitro and in vivo trials 370 
assays with organ-specific response [61, 62, 64, 65].  371 
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In addition to il1b, the microalgal crude extract also stimulated the expression of 372 
chaperone hsp90aa in kidney and spleen and the antimicrobial peptide hamp1 in the three 373 
tissues although with a high variable response among specimens. The expression of hsp90 374 
and il1b is up-regulated in a mutant zebrafish that lacks an adaptive immune response 375 
[66]. The co-expression was associated with the role of Hsp90 in ensuring the correct 376 
folding of several kinases and intermediates of the NF-κB signalling pathway and hence 377 
modulating NF-κB action and pro-inflammatory cytokine production in macrophages 378 
[67-69]. The modification of hepcidin expression in soles injected with the microalgal 379 
extract may be related to its stimulation by pro-inflammatory cytokines such as IL-6 [70] 380 
and to the inhibitory effect on cytokine production through interfering the NF-κB pathway 381 
[71]. Interestingly, a similar activation pattern of pro-inflammatory cytokines (il1b, il6, 382 
and tnfa) and hamp1 was also observed by our group in kidney and intestine of juvenile 383 
soles after infection with LCDV [42] indicating that this microalgal extract promotes the 384 
up-regulation of genes representative of an acute innate response against a pathogen.  385 
In contrast to the fast activation of the inflammatory response at 2 dpi, genes related with 386 
the response to virus, ifn1, irf1, irf3, irf8, irf9 and mx, and the chemokine cxc10 were 387 
down-regulated in the kidney and/or spleen at 5 dpi and the sugar receptor clec in kidney 388 
(1.5-fold lower) at 2 dpi. The stabilization of mortality after 5-6 dpi observed in this study 389 
also supports the acute response as the primary cause for the expression patterns observed. 390 
In this regards, chrysolaminarin-enriched extract reinjection at 7 dpi did not induce further 391 
mortality and did not activate a pro-inflammatory response. Instead, a decrease of 392 
hsp90aa and irf3 mRNA levels were measured as indicative of some resistance of sole to 393 
consequent injections of chrysolaminarin. A previous study in Labeo rohita fingerlings 394 
identified that only three out four injections of β-glucans and at a moderate concentration 395 
specifically maintained enhanced phagocytic cell functions [59]. All these data suggest 396 
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that the β-glucan exposure rapidly activated an acute inflammatory response but in the 397 
absence of a pathogen down-regulation of transcripts to restore the steady-state levels 398 
occurred. Clearly it will be relevant in the future to assess how β-glucan supplementation 399 
via diet changes the efficacy of the immune response to pathogens 400 
5. Conclusion 401 
This study demonstrates that crude extract from P. tricornutum enriched in 402 
chrysolaminarin has a potent antioxidant capacity and impairs cell growth at 403 
concentrations higher than 0.01%. In vivo testing of immunomodulatory actions in sole 404 
demonstrated that they induce a fast (2 dpi) and transient activation of the pro-405 
inflammatory il1b and stress defence mechanisms in kidney, spleen and intestine that was 406 
not clearly observable later at 5 dpi. Overall, the results support this microalgal extract 407 
enriched in β-glucans as a novel product with a high potential to be used in aquaculture. 408 
Further research will be required to identify all active metabolites in the extracts and to 409 
establish optimal doses and delivery routes to enhance immune system and protection 410 
against infection diseases. 411 
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Table 1 653 
Primers used for RT-qPCR. Gene names, primer sequences, amplicon size and the target unigene from SoleaDB 654 
(Benzekri et al., 2014) are indicated.  655 
 656 
Target Primer Sequence (5’®3’) Amplicon (bp) source 
il1b F GCACCCTCATGTCTGCCCGCTTCCCT 
105 unigene346347  R AGGTTCTGTAGCGTTGGGCCATCTCTGT 
tnfa F CCAAGCGTTTGCTCAGGGCGGCTTC 
116 unigene26860  R GGCCTTCGCTGCAGGAGACTCTGAACGAC 
clec F CCCCCATCGTCTGCCCTCTGAACTGG  90 unigene416724  R ACTGACTCTCGTCCCACTCTCTGAAGACCC 
cxc10 F CGCGCTCGACAACAGCCAGTCAAAGCAAC 121 unigene30191 
 R ACAGTGACAGTGCTGGTGAGGAACTCCTT 
irf7 F GGCAAAATCAGCGAGTTCCCCAACGACA 93 unigene68007 
 R CACCATCTTGAAGCGCACGGACAGGTT 
irf8 F AGCCTGCGACATGGAAGACAAGACTCCG 86 unigene17110  R GTCCAGCTGCGACCGTTCTCTCACCTCC 
irf9 F TCACCGTGCAGACCGAGGAGCCCGTT  
79 unigene2689_split_1  R TCCAGTCTGATCTCGTCCACCGCGTCTCT 
ifn1 F AGCACAAGGAAAGCGCTGCCTGTGGT  
94 unigene638812  R AAGCAGTTGTGGTGTTTGTGCAGGACGAT 
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Captions 663 
 664 
Figure 1. Experimental design. Soles (19.3 ± 3.3 g) were acclimated for 1 week before i.p. injection. Chrysolaminarin-enriched extract was 665 
suspended in a coconut oil and PBS emulsion (1:1) and injected 1mg/fish (Chrysolaminarin group) and the sham control group just with the 666 
emulsion. At 7 dpi (dash line), the chrysolaminarin-injected fish were reinjected with chrysolaminarin (Chr_Chr group) or the emulsion (Chr_C 667 
group) whereas the sham control group was reinjected only with the emulsion (C_C group) Mortality was monitored for 13 days and samplings 668 
were carried out at 2 and 5 dpi and 2 days after reinjection.  669 
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 670 
 671 
Figure 2. Total antioxidant capacity (TAC) of chrysolaminarin and yeast β-glucan. (A) the oxygen radical absorbance capacity (ORAC) assay. 672 
(B) ferric reducing antioxidant power (FRAP). (C) the 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging assay. ORAC values were 673 
expressed as Trolox equivalents (μmol Trolox/g), FRAP as μg ascorbic acid/mg and DPPH as percentage of scavenging of free radical. 674 
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 676 
Figure 3. (A) Toxicity of chrysolaminarin-enriched extract and yeast glucan in human fibroblast cells as determined by MTT. Asterisks indicate 677 
significant differences with respect to the lower concentration. *p<0.05; ** p<0.01; *** p<0.001. (B) In vivo cumulative mortality in sole 678 
intraperitoneally injected with chrysolaminarin-enriched extract. The experimental groups Chr_Chr, Chr_C and C_C are indicated 679 
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 681 
Figure 4. Hierarchical clustering analysis based on set of expressed transcripts in kidney (A), intestine (B) and spleen (C) as determined by 682 
qPCR. Data were normalized and expressed as log10 of fold change. Green and red colours indicate low and high expression values according to 683 
the scale shown. The samples are identified on the right (control and chrysolaminarin-enriched extract at 2 and 5 dpi) and the main clusters 684 
grouping separating both experimental group samples are boxed in blue. Full-names for the transcripts shown on the top are indicated in M&M.  685 
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 687 
Figure 5. Differentially expressed genes in kidney after i.p. injection of the chrysolaminarin-enriched extract. Data were expressed as the mean 688 
fold change (mean + SEM, n = 3) from the calibrator (control 2 dpi). A two-way ANOVA was used to determine statistical differences. Asterisks 689 
denote significant differences between control (white) and chrysolaminarin-enriched extract (black) injected fish. § indicates significant differences 690 
due to time.   691 
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 692 
Figure 6. Differentially expressed genes in intestine (A) and spleen (B) after i.p. injection of the chrysolaminarin-enriched extract. Data were 693 
expressed as the mean fold change (mean + SEM, n = 3) from the calibrator (control 2 dpi). A two-way ANOVA was used to determine statistical 694 
differences. Asterisks denote significant differences between control (white) and chrysolaminarin-enriched extract (black) injected fish.  695 
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